Latest WEHI News | Page 4

CSL Research and Development Day 2021
Research-industry partnership to advance biologic therapies
Could dietary changes help reduce pregnancy complications in women with type 1 diabetes?
QUT Honorary Doctorate recipients awarded
Melbourne-made Covid treatment could future-proof Australia
$13M boost for international mother-baby iron supplements study
Bright ideas among $31M Australian Government funding boost
New therapeutic target pinpointed for stomach cancer
Iron deficiency can be managed better
Survival protein may prevent collateral damage during cancer therapy
Malaria and immunology researchers win Burnet Prize
National recognition for WEHI bioinformatics researchers
Nanobodies could hold clues to new COVID-19 therapies
Mother’s touch lingers in her child’s genes
Medical researcher recognised as top Melburnian
WEHI director named 2020 Melburnian of Year
Potential new target to combat inflammatory diseases
Study investigating causes of stuttering
Animation reveals secrets of critical tumour protein
WEHI joins forces with World Health Organisation to combat anaemia
Leukaemia researcher Professor Andrew Roberts joint winner of Ramaciotti Medal
‘Multi-omics’ adds new cell to immune family tree
WEHI embarks on a new era of scientific discovery
Clinical study aims to better understand COVID-19 immunity
Motor neuron disease inflammation trigger discovered
Taking STING out of MND
New therapeutic target identified for rare virus-associated lymphomas
RethiNKing which immune cells are best weapon against lung cancer
Search for COVID-19 drugs boosted by SARS discovery
Lockdowns have economic and social costs for world’s poorest families
Iron study combats anaemia with cutting-edge computer simulation
Enemy within: safeguarding against spread of intracellular bacteria
New c-FIND test accurately diagnoses infection in minutes
New light shone on inflammatory cell death regulator
New structural ‘map’ solves mysteries of gigantic gene regulator
Queen’s Birthday Honour for blood cancer researcher
Australian Government invests in new medicines for COVID-19
Human insulin enhanced with cone snail ‘blue print’
Blood cancer researcher elected Academy Fellow
COVID19 prevention trial opens for high risk healthcare workers
Four new projects announced for National Drug Discovery Centre
Mucus breakthrough could help patients breathe easy
Blood test a potential new tool for controlling infections
Killing ‘sleeper cells’ may enhance breast cancer therapy
Dual personalities visualised for shape-shifting molecule
Breast cancer ‘signature’ predicts response to new drug class
Breast cancer researcher recognised by UK Royal Society
Offspring may inherit legacy of their father’s Toxoplasma infection